- Home
- ULBI vs ABOS Comparison
ULBI vs ABOS Comparison
Compare ULBI & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ULBI
- ABOS
- Stock Information
- Founded
- ULBI 1990
- ABOS 1996
- Country
- ULBI United States
- ABOS United States
- Employees
- ULBI N/A
- ABOS N/A
- Industry
- ULBI Industrial Machinery/Components
- ABOS Biotechnology: Pharmaceutical Preparations
- Sector
- ULBI Miscellaneous
- ABOS Health Care
- Exchange
- ULBI Nasdaq
- ABOS Nasdaq
- Market Cap
- ULBI 158.1M
- ABOS 171.8M
- IPO Year
- ULBI 1992
- ABOS 2021
- Fundamental
- Price
- ULBI $7.67
- ABOS $2.51
- Analyst Decision
- ULBI Strong Buy
- ABOS Strong Buy
- Analyst Count
- ULBI 1
- ABOS 4
- Target Price
- ULBI $14.00
- ABOS $9.00
- AVG Volume (30 Days)
- ULBI 63.5K
- ABOS 245.2K
- Earning Date
- ULBI 11-08-2024
- ABOS 11-12-2024
- Dividend Yield
- ULBI N/A
- ABOS N/A
- EPS Growth
- ULBI 115.20
- ABOS N/A
- EPS
- ULBI 0.54
- ABOS N/A
- Revenue
- ULBI $165,152,000.00
- ABOS N/A
- Revenue This Year
- ULBI $10.59
- ABOS N/A
- Revenue Next Year
- ULBI $8.72
- ABOS N/A
- P/E Ratio
- ULBI $14.73
- ABOS N/A
- Revenue Growth
- ULBI 9.95
- ABOS N/A
- 52 Week Low
- ULBI $6.36
- ABOS $2.08
- 52 Week High
- ULBI $13.39
- ABOS $5.09
- Technical
- Relative Strength Index (RSI)
- ULBI 34.02
- ABOS 42.71
- Support Level
- ULBI $7.50
- ABOS $2.52
- Resistance Level
- ULBI $8.17
- ABOS $3.36
- Average True Range (ATR)
- ULBI 0.36
- ABOS 0.23
- MACD
- ULBI -0.10
- ABOS -0.06
- Stochastic Oscillator
- ULBI 9.00
- ABOS 5.95
About ULBI Ultralife Corporation
Ultralife Corp provides products and services ranging from power solutions to communications and electronics systems to customers across the globe in the government and defense, medical, safety and security, energy, and industrial sectors. The company designs, manufactures, installs, and maintains power and communications systems including rechargeable and non-rechargeable batteries, charging systems, communications and electronics systems and accessories, and custom-engineered systems. The company's segments include Battery and Energy Products, and Communications Systems. It generates maximum revenue from the Battery and Energy Products segment, and from the U.S. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, and various other non-rechargeable batteries.
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.